Thymic carcinoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
| Line 21: | Line 21: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Surgery]] | |||
Revision as of 17:13, 27 November 2017
|
Thymic Carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymic carcinoma surgery On the Web |
|
American Roentgen Ray Society Images of Thymic carcinoma surgery |
|
Risk calculators and risk factors for Thymic carcinoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Surgery is the mainstay of treatment for thymic carcinoma.[1]
Surgery
Treatment options for thymic carcinoma include the following:[1]
- Surgery
- Radiation
- Cisplatin-based chemotherapy
- For patients with clinically resectable disease, surgical resection is often the initial therapeutic intervention.
- For clinically borderline or frankly unresectable lesions, neoadjuvant (preoperative) chemotherapy or thoracic radiation therapy, or both, is given.
- Patients presenting with locally advanced disease should be carefully evaluated and undergo multimodality therapy.
- Patients with poor performance status and high associated operative risks are generally not considered for these types of aggressive treatments.
- Patients with metastatic disease may respond to combination chemotherapy.
References
- ↑ 1.0 1.1 National Cancer Institute. General Information About Thymoma and Thymic Carcinoma Treatment. http://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq. Accessed on 22nd December, 2015.